HLA-DOA: Difference between revisions

Jump to navigation Jump to search
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}))
 
m (Bot: HTTP→HTTPS (v470))
 
Line 1: Line 1:
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{Infobox_gene}}
{{PBB_Controls
'''HLA class II histocompatibility antigen, DO alpha chain''' is a [[protein]] that in humans is encoded by the ''HLA-DOA'' [[gene]].<ref name="pmid2370084">{{cite journal |vauthors=Young JA, Trowsdale J | title = The HLA-DNA (DZA) gene is correctly expressed as a 1.1 kb mature mRNA transcript | journal = Immunogenetics | volume = 31 | issue = 5–6 | pages = 386–8 |date=Aug 1990 | pmid = 2370084 | pmc =  | doi =10.1007/BF02115015 }}</ref><ref name="entrez">{{cite web | title = Entrez Gene: HLA-DOA major histocompatibility complex, class II, DO alpha| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3111| accessdate = }}</ref>
| update_page = yes
| require_manual_inspection = no
| update_protein_box = yes
| update_summary = yes
| update_citations = yes
}}
 
<!-- The GNF_Protein_box is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{GNF_Protein_box
| image = 
| image_source = 
| PDB =  
| Name = Major histocompatibility complex, class II, DO alpha
| HGNCid = 4936
| Symbol = HLA-DOA
| AltSymbols =; HLA-DNA; HLA-DZA; HLADZ
| OMIM = 142930
| ECnumber = 
| Homologene = 1601
| MGIid = 95924
| GeneAtlas_image1 = PBB_GE_HLA-DOA_206313_at_tn.png
| GeneAtlas_image2 = PBB_GE_HLA-DOA_211142_x_at_tn.png
| Function = {{GNF_GO|id=GO:0032395 |text = MHC class II receptor activity}}
| Component = {{GNF_GO|id=GO:0005886 |text = plasma membrane}} {{GNF_GO|id=GO:0016021 |text = integral to membrane}} {{GNF_GO|id=GO:0042613 |text = MHC class II protein complex}}
| Process = {{GNF_GO|id=GO:0002504 |text = antigen processing and presentation of peptide or polysaccharide antigen via MHC class II}} {{GNF_GO|id=GO:0006955 |text = immune response}} {{GNF_GO|id=GO:0019886 |text = antigen processing and presentation of exogenous peptide antigen via MHC class II}} {{GNF_GO|id=GO:0045580 |text = regulation of T cell differentiation}}
  | Orthologs = {{GNF_Ortholog_box
    | Hs_EntrezGene = 3111
    | Hs_Ensembl = ENSG00000204252
    | Hs_RefseqProtein = NP_002110
    | Hs_RefseqmRNA = NM_002119
    | Hs_GenLoc_db = 
    | Hs_GenLoc_chr = 6
    | Hs_GenLoc_start = 33079937
    | Hs_GenLoc_end = 33085367
    | Hs_Uniprot = P06340
    | Mm_EntrezGene = 15001
    | Mm_Ensembl = ENSMUSG00000024334
    | Mm_RefseqmRNA = NM_008206
    | Mm_RefseqProtein = NP_032232
    | Mm_GenLoc_db = 
    | Mm_GenLoc_chr = 17
    | Mm_GenLoc_start = 33702901
    | Mm_GenLoc_end = 33705273
    | Mm_Uniprot =   
  }}
}}
'''Major histocompatibility complex, class II, DO alpha''', also known as '''HLA-DOA''', is a human [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: HLA-DOA major histocompatibility complex, class II, DO alpha| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3111| accessdate = }}</ref>


<!-- The PBB_Summary template is automatically maintained by Protein Box Bot.  See Template:PBB_Controls to Stop updates. -->
<!-- The PBB_Summary template is automatically maintained by Protein Box Bot.  See Template:PBB_Controls to Stop updates. -->
{{PBB_Summary
{{PBB_Summary
| section_title =  
| section_title =  
| summary_text = HLA-DOA belongs to the HLA class II alpha chain paralogues. HLA-DOA forms a heterodimer with HLA-DOB. The heterodimer, HLA-DO, is found in lysosomes in B cells and regulates HLA-DM-mediated peptide loading on MHC class II molecules. In comparison with classical HLA class II molecules, this gene exhibits very little sequence variation, especially at the protein level.<ref name="entrez">{{cite web | title = Entrez Gene: HLA-DOA major histocompatibility complex, class II, DO alpha| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3111| accessdate = }}</ref>
| summary_text = HLA-DOA belongs to the HLA class II alpha chain paralogues. HLA-DOA forms a heterodimer with HLA-DOB. The heterodimer, HLA-DO, is found in lysosomes in B cells and regulates HLA-DM-mediated peptide loading on MHC class II molecules. In comparison with classical HLA class II molecules, this gene exhibits very little sequence variation, especially at the protein level.<ref name="entrez"/>
}}
}}


==References==
==References==
{{reflist|2}}
{{reflist}}
 
==Further reading==
==Further reading==
{{refbegin | 2}}
{{refbegin | 2}}
{{PBB_Further_reading  
{{PBB_Further_reading  
| citations =  
| citations =  
*{{cite journal | author=Piatier-Tonneau D, Gastinel LN, Amblard F, ''et al.'' |title=Interaction of CD4 with HLA class II antigens and HIV gp120. |journal=Immunogenetics |volume=34 |issue= 2 |pages= 121-8 |year= 1991 |pmid= 1869305 |doi=  }}
*{{cite journal   |vauthors=Piatier-Tonneau D, Gastinel LN, Amblard F, etal |title=Interaction of CD4 with HLA class II antigens and HIV gp120 |journal=Immunogenetics |volume=34 |issue= 2 |pages= 121–8 |year= 1991 |pmid= 1869305 |doi=10.1007/BF00211424 }}
*{{cite journal  | author=Rosenstein Y, Burakoff SJ, Herrmann SH |title=HIV-gp120 can block CD4-class II MHC-mediated adhesion. |journal=J. Immunol. |volume=144 |issue= 2 |pages= 526-31 |year= 1990 |pmid= 1967269 |doi=  }}
*{{cite journal  |vauthors=Rosenstein Y, Burakoff SJ, Herrmann SH |title=HIV-gp120 can block CD4-class II MHC-mediated adhesion |journal=J. Immunol. |volume=144 |issue= 2 |pages= 526–31 |year= 1990 |pmid= 1967269 |doi=  }}
*{{cite journal  | author=Bowman MR, MacFerrin KD, Schreiber SL, Burakoff SJ |title=Identification and structural analysis of residues in the V1 region of CD4 involved in interaction with human immunodeficiency virus envelope glycoprotein gp120 and class II major histocompatibility complex molecules. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=87 |issue= 22 |pages= 9052-6 |year= 1991 |pmid= 1978941 |doi= }}
*{{cite journal  |vauthors=Bowman MR, MacFerrin KD, Schreiber SL, Burakoff SJ |title=Identification and structural analysis of residues in the V1 region of CD4 involved in interaction with human immunodeficiency virus envelope glycoprotein gp120 and class II major histocompatibility complex molecules |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=87 |issue= 22 |pages= 9052–6 |year= 1991 |pmid= 1978941 |doi=10.1073/pnas.87.22.9052  | pmc=55099  }}
*{{cite journal  | author=Rosen-Bronson S, Long EO |title=An unusual form of alternative splicing in the HLA-DNA gene. |journal=Immunogenetics |volume=33 |issue= 2 |pages= 124-31 |year= 1991 |pmid= 1999352 |doi=  }}
*{{cite journal  |vauthors=Rosen-Bronson S, Long EO |title=An unusual form of alternative splicing in the HLA-DNA gene |journal=Immunogenetics |volume=33 |issue= 2 |pages= 124–31 |year= 1991 |pmid= 1999352 |doi=10.1007/BF00210826 }}
*{{cite journal  | author=Young JA, Trowsdale J |title=The HLA-DNA (DZA) gene is correctly expressed as a 1.1 kb mature mRNA transcript. |journal=Immunogenetics |volume=31 |issue= 5-6 |pages= 386-8 |year= 1990 |pmid= 2370084 |doi=  }}
*{{cite journal  |vauthors=Jonsson AK, Rask L |title=Human class II DNA and DOB genes display low sequence variability |journal=Immunogenetics |volume=29 |issue= 6 |pages= 411–3 |year= 1989 |pmid= 2499532 |doi=10.1007/BF00375872 }}
*{{cite journal  | author=Jonsson AK, Rask L |title=Human class II DNA and DOB genes display low sequence variability. |journal=Immunogenetics |volume=29 |issue= 6 |pages= 411-3 |year= 1989 |pmid= 2499532 |doi= }}
*{{cite journal  |vauthors=Clayton LK, Sieh M, Pious DA, Reinherz EL |title=Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding |journal=Nature |volume=339 |issue= 6225 |pages= 548–51 |year= 1989 |pmid= 2543930 |doi= 10.1038/339548a0 }}
*{{cite journal | author=Clayton LK, Sieh M, Pious DA, Reinherz EL |title=Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding. |journal=Nature |volume=339 |issue= 6225 |pages= 548-51 |year= 1989 |pmid= 2543930 |doi= 10.1038/339548a0 }}
*{{cite journal   |vauthors=Diamond DC, Sleckman BP, Gregory T, etal |title=Inhibition of CD4+ T cell function by the HIV envelope protein, gp120 |journal=J. Immunol. |volume=141 |issue= 11 |pages= 3715–7 |year= 1988 |pmid= 2846691 |doi= }}
*{{cite journal  | author=Diamond DC, Sleckman BP, Gregory T, ''et al.'' |title=Inhibition of CD4+ T cell function by the HIV envelope protein, gp120. |journal=J. Immunol. |volume=141 |issue= 11 |pages= 3715-7 |year= 1988 |pmid= 2846691 |doi=  }}
*{{cite journal  |vauthors=Inoko H, Ando A, Kimura M, Tsuji K |title=Isolation and characterization of the cDNA clone and genomic clones of a new HLA class II antigen heavy chain, DO alpha |journal=J. Immunol. |volume=135 |issue= 3 |pages= 2156–9 |year= 1985 |pmid= 2991382 |doi=  }}
*{{cite journal  | author=Inoko H, Ando A, Kimura M, Tsuji K |title=Isolation and characterization of the cDNA clone and genomic clones of a new HLA class II antigen heavy chain, DO alpha. |journal=J. Immunol. |volume=135 |issue= 3 |pages= 2156-9 |year= 1985 |pmid= 2991382 |doi=  }}
*{{cite journal  |vauthors=Trowsdale J, Kelly A |title=The human HLA class II alpha chain gene DZ alpha is distinct from genes in the DP, DQ and DR subregions |journal=EMBO J. |volume=4 |issue= 9 |pages= 2231–7 |year= 1986 |pmid= 3000765 |doi= | pmc=554490 }}
*{{cite journal  | author=Trowsdale J, Kelly A |title=The human HLA class II alpha chain gene DZ alpha is distinct from genes in the DP, DQ and DR subregions. |journal=EMBO J. |volume=4 |issue= 9 |pages= 2231-7 |year= 1986 |pmid= 3000765 |doi=  }}
*{{cite journal  |vauthors=Andrieu JM, Even P, Venet A |title=AIDS and related syndromes as a viral-induced autoimmune disease of the immune system: an anti-MHC II disorder. Therapeutic implications |journal=AIDS research |volume=2 |issue= 3 |pages= 163–74 |year= 1986 |pmid= 3489470 |doi=  10.1089/aid.1.1986.2.163}}
*{{cite journal | author=Andrieu JM, Even P, Venet A |title=AIDS and related syndromes as a viral-induced autoimmune disease of the immune system: an anti-MHC II disorder. Therapeutic implications. |journal=AIDS research |volume=2 |issue= 3 |pages= 163-74 |year= 1986 |pmid= 3489470 |doi=  }}
*{{cite journal   |vauthors=Houlgatte R, Scarmato P, el Marhomy S, etal |title=HLA class II antigens and the HIV envelope glycoprotein gp120 bind to the same face of CD4 |journal=J. Immunol. |volume=152 |issue= 9 |pages= 4475–88 |year= 1994 |pmid= 7512597 |doi=  }}
*{{cite journal | author=Houlgatte R, Scarmato P, el Marhomy S, ''et al.'' |title=HLA class II antigens and the HIV envelope glycoprotein gp120 bind to the same face of CD4. |journal=J. Immunol. |volume=152 |issue= 9 |pages= 4475-88 |year= 1994 |pmid= 7512597 |doi=  }}
*{{cite journal   |vauthors=Chirmule N, McCloskey TW, Hu R, etal |title=HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71) |journal=J. Immunol. |volume=155 |issue= 2 |pages= 917–24 |year= 1995 |pmid= 7541827 |doi=  }}
*{{cite journal  | author=Chirmule N, McCloskey TW, Hu R, ''et al.'' |title=HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71). |journal=J. Immunol. |volume=155 |issue= 2 |pages= 917-24 |year= 1995 |pmid= 7541827 |doi=  }}
*{{cite journal  |vauthors=Rowell JF, Stanhope PE, Siliciano RF |title=Endocytosis of endogenously synthesized HIV-1 envelope protein. Mechanism and role in processing for association with class II MHC |journal=J. Immunol. |volume=155 |issue= 1 |pages= 473–88 |year= 1995 |pmid= 7602119 |doi=  }}
*{{cite journal | author=Rowell JF, Stanhope PE, Siliciano RF |title=Endocytosis of endogenously synthesized HIV-1 envelope protein. Mechanism and role in processing for association with class II MHC. |journal=J. Immunol. |volume=155 |issue= 1 |pages= 473-88 |year= 1995 |pmid= 7602119 |doi=  }}
*{{cite journal   |vauthors=Chen YH, Böck G, Vornhagen R, etal |title=HIV-1 gp41 binding proteins and antibodies to gp41 could inhibit enhancement of human Raji cell MHC class I and II expression by gp41 |journal=Mol. Immunol. |volume=31 |issue= 13 |pages= 977–82 |year= 1994 |pmid= 8084338 |doi=10.1016/0161-5890(94)90092-2 }}
*{{cite journal | author=Chen YH, Böck G, Vornhagen R, ''et al.'' |title=HIV-1 gp41 binding proteins and antibodies to gp41 could inhibit enhancement of human Raji cell MHC class I and II expression by gp41. |journal=Mol. Immunol. |volume=31 |issue= 13 |pages= 977-82 |year= 1994 |pmid= 8084338 |doi= }}
*{{cite journal   |vauthors=Chirmule N, Wang XP, Hu R, etal |title=Envelope glycoproteins of HIV-1 interfere with T-cell-dependent B cell differentiation: role of CD4-MHC class II interaction in the effector phase of T cell help |journal=Cell. Immunol. |volume=155 |issue= 1 |pages= 169–82 |year= 1994 |pmid= 8168144 |doi= 10.1006/cimm.1994.1110 }}
*{{cite journal | author=Chirmule N, Wang XP, Hu R, ''et al.'' |title=Envelope glycoproteins of HIV-1 interfere with T-cell-dependent B cell differentiation: role of CD4-MHC class II interaction in the effector phase of T cell help. |journal=Cell. Immunol. |volume=155 |issue= 1 |pages= 169-82 |year= 1994 |pmid= 8168144 |doi= 10.1006/cimm.1994.1110 }}
*{{cite journal   |vauthors=Callahan KM, Rowell JF, Soloski MJ, etal |title=HIV-1 envelope protein is expressed on the surface of infected cells before its processing and presentation to class II-restricted T lymphocytes |journal=J. Immunol. |volume=151 |issue= 6 |pages= 2928–42 |year= 1993 |pmid= 8376762 |doi= }}
*{{cite journal | author=Callahan KM, Rowell JF, Soloski MJ, ''et al.'' |title=HIV-1 envelope protein is expressed on the surface of infected cells before its processing and presentation to class II-restricted T lymphocytes. |journal=J. Immunol. |volume=151 |issue= 6 |pages= 2928-42 |year= 1993 |pmid= 8376762 |doi=  }}
*{{cite journal   |vauthors=Liljedahl M, Kuwana T, Fung-Leung WP, etal |title=HLA-DO is a lysosomal resident which requires association with HLA-DM for efficient intracellular transport |journal=EMBO J. |volume=15 |issue= 18 |pages= 4817–24 |year= 1996 |pmid= 8890155 |doi= | pmc=452218 }}
*{{cite journal | author=Liljedahl M, Kuwana T, Fung-Leung WP, ''et al.'' |title=HLA-DO is a lysosomal resident which requires association with HLA-DM for efficient intracellular transport. |journal=EMBO J. |volume=15 |issue= 18 |pages= 4817-24 |year= 1996 |pmid= 8890155 |doi=  }}
*{{cite journal   |vauthors=Ruff AL, Guarnieri FG, Staveley-O'Carroll K, etal |title=The enhanced immune response to the HIV gp160/LAMP chimeric gene product targeted to the lysosome membrane protein trafficking pathway |journal=J. Biol. Chem. |volume=272 |issue= 13 |pages= 8671–8 |year= 1997 |pmid= 9079699 |doi=10.1074/jbc.272.13.8671 }}
*{{cite journal  | author=Ruff AL, Guarnieri FG, Staveley-O'Carroll K, ''et al.'' |title=The enhanced immune response to the HIV gp160/LAMP chimeric gene product targeted to the lysosome membrane protein trafficking pathway. |journal=J. Biol. Chem. |volume=272 |issue= 13 |pages= 8671-8 |year= 1997 |pmid= 9079699 |doi= }}
*{{cite journal  |vauthors=Douek DC, Altmann DM |title=HLA-DO is an intracellular class II molecule with distinctive thymic expression |journal=Int. Immunol. |volume=9 |issue= 3 |pages= 355–64 |year= 1997 |pmid= 9088974 |doi=10.1093/intimm/9.3.355  }}
*{{cite journal  | author=Douek DC, Altmann DM |title=HLA-DO is an intracellular class II molecule with distinctive thymic expression. |journal=Int. Immunol. |volume=9 |issue= 3 |pages= 355-64 |year= 1997 |pmid= 9088974 |doi= }}
}}
}}
{{refend}}
{{refend}}


{{protein-stub}}
{{Surface antigens}}
{{WikiDoc Sources}}
 
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{PBB_Controls
| update_page = yes
| require_manual_inspection = no
| update_protein_box = yes
| update_summary = yes
| update_citations = yes
}}
 
[[Category:MHC Class II]]
 
 
{{immunology-stub}}
{{gene-6-stub}}

Latest revision as of 02:09, 27 October 2017

VALUE_ERROR (nil)
Identifiers
Aliases
External IDsGeneCards: [1]
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

n/a

n/a

RefSeq (protein)

n/a

n/a

Location (UCSC)n/an/a
PubMed searchn/an/a
Wikidata
View/Edit Human

HLA class II histocompatibility antigen, DO alpha chain is a protein that in humans is encoded by the HLA-DOA gene.[1][2]

HLA-DOA belongs to the HLA class II alpha chain paralogues. HLA-DOA forms a heterodimer with HLA-DOB. The heterodimer, HLA-DO, is found in lysosomes in B cells and regulates HLA-DM-mediated peptide loading on MHC class II molecules. In comparison with classical HLA class II molecules, this gene exhibits very little sequence variation, especially at the protein level.[2]

References

  1. Young JA, Trowsdale J (Aug 1990). "The HLA-DNA (DZA) gene is correctly expressed as a 1.1 kb mature mRNA transcript". Immunogenetics. 31 (5–6): 386–8. doi:10.1007/BF02115015. PMID 2370084.
  2. 2.0 2.1 "Entrez Gene: HLA-DOA major histocompatibility complex, class II, DO alpha".

Further reading